LONDON, July 27 (Reuters) - GlaxoSmithKline plans275 million pounds ($361 million) of new investments at threedrug manufacturing sites in Britain, signalling its confidencein the country despite last month's vote to leave the EuropeanUnion. (Reporting by Ben Hirschler; Editing by David Holmes)
LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California
(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.
Read more